Senior Scientist in Business Development for Search & Evaluation

Are you energized by early-stage science and the hunt for the next platform, target, or enabling technology that can change what is possible in drug discovery? We are looking for a Senior Scientist to identify and evaluate external innovation - from novel targets and therapeutic concepts to enabling technologies - and translate this into opportunities for our Biotech pipeline.

[xxxxx]is a Danish-founded biotech and CRO with deep expertise in early drug development. We are pursuing an ambitious growth strategy and is expanding our Business Development team to scale external innovation, while in parallel advancing streaMLine, our AI/ML-powered peptide drug discovery platform that enables rapid progression from target identification to preclinical candidate selection.

What you will do

In this cross-disciplinary role you will operate at the intersection of science, strategy, and collaboration focusing on identifying and evaluating opportunities. Your work will directly inform partnership and M&A discussions and will help shape Gubra’s innovation roadmap.

Your primary areas of responsibility will be:

• Scout and evaluate early-stage targets, technologies, and external opportunities relevant to Gubra’s therapeutic focus and platform strategy.
• Perform scientific due diligence to evaluate potential fit, for example assessing novelty, biological rationale, translational potential, differentiation, key risks, and the competitive landscape.
• Create decision-ready materials that enable clear go/no-go recommendations.
• Build and maintain an external landscape view by tracking publications, preprints, patents, conferences, and emerging companies to identify opportunities and threats.
• Attend scientific meetings and build relationships with researchers, founders, and partner organizations.
• Contribute to internal projects as needed, including target and asset evaluations and early discovery support.

We are looking for a person with:

• PhD in life sciences or a closely related field.
• Demonstrated experience in drug discovery and a strong ability to evaluate biological and pharmacological data.
• Broad scientific curiosity and the judgment to assess diverse approaches, from target biology to enabling technologies.
• Strong written and verbal communication skills with the ability to synthesize complex science into concise, decision-ready recommendations.
• A proactive, entrepreneurial mindset and comfortable working in a small team in a fast-changing environment.
• Structured, analytical, hands-on working style and the ability to manage multiple priorities.

Nice to have:

• Experience with peptide-based drug discovery and/or target discovery.
• Existing academic or industry networks relevant to early discovery, platform technologies, or partnering.

Please apply no later than February 16, 2026 by uploading your motivated cover letter, resumé, and relevant diplomas on our website. Please apply as soon as possible and note that applications will be reviewed on an ongoing basis. If you have questions about the position, please contact Head of [xxxxx]US, Frederik Friis-Hansen [xxxxx]

This position is onsite in our Cambridge office.

About Gubra 

[xxxxx]is a disease-agnostic techbio company specialized in peptide-based drug discovery and preclinical contract research services striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the path towards a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.

Gubra’s activities are focused on the early stages of drug development and are organised in two main highly synergistic business areas: Biotech and CRO Services. We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.

Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.

People are our greatest asset, and our team consists of around 300 employees. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!